Please select the option that best describes you:

How would you approach a patient with metastatic colon cancer and BRCA2 mutation in next generation sequencing?   

Would you consider using PARP Inhibitor in this situation? 



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University Medical Oncology
Thank you very much!
Sign in or Register to read more